Los Angeles Capital Management LLC Rapt Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 201,439 shares of RAPT stock, worth $177,266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
201,439
Previous 84,586
138.15%
Holding current value
$177,266
Previous $257,000
57.2%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RAPT
# of Institutions
104Shares Held
27.1MCall Options Held
26.7KPut Options Held
2.4K-
Vanguard Group Inc Valley Forge, PA3.16MShares$2.78 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$2.36 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.15 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$1.52 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$1.41 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $26.1M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...